85 related articles for article (PubMed ID: 15625130)
1. Enforced expression of PU.1 rescues osteoclastogenesis from embryonic stem cells lacking Tal-1.
Tsuneto M; Tominaga A; Yamazaki H; Yoshino M; Orkin SH; Hayashi S
Stem Cells; 2005; 23(1):134-43. PubMed ID: 15625130
[TBL] [Abstract][Full Text] [Related]
2. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
[TBL] [Abstract][Full Text] [Related]
3. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Schuringa JJ; Wu K; Morrone G; Moore MA
Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
[TBL] [Abstract][Full Text] [Related]
4. In vitro hematopoietic differentiation of human embryonic stem cells induced by co-culture with human bone marrow stromal cells and low dose cytokines.
Wang J; Zhao HP; Lin G; Xie CQ; Nie DS; Wang QR; Lu GX
Cell Biol Int; 2005 Aug; 29(8):654-61. PubMed ID: 15950498
[TBL] [Abstract][Full Text] [Related]
5. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
6. Derivation of melanocytes from embryonic stem cells in culture.
Yamane T; Hayashi S; Mizoguchi M; Yamazaki H; Kunisada T
Dev Dyn; 1999 Dec; 216(4-5):450-8. PubMed ID: 10633864
[TBL] [Abstract][Full Text] [Related]
7. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse.
Ema M; Faloon P; Zhang WJ; Hirashima M; Reid T; Stanford WL; Orkin S; Choi K; Rossant J
Genes Dev; 2003 Feb; 17(3):380-93. PubMed ID: 12569129
[TBL] [Abstract][Full Text] [Related]
8. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.
Tondravi MM; McKercher SR; Anderson K; Erdmann JM; Quiroz M; Maki R; Teitelbaum SL
Nature; 1997 Mar; 386(6620):81-4. PubMed ID: 9052784
[TBL] [Abstract][Full Text] [Related]
9. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene.
Mikkola HK; Klintman J; Yang H; Hock H; Schlaeger TM; Fujiwara Y; Orkin SH
Nature; 2003 Jan; 421(6922):547-51. PubMed ID: 12540851
[TBL] [Abstract][Full Text] [Related]
10. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide suppresses RANK gene expression in macrophages by down-regulating PU.1 and MITF.
Ishii J; Kitazawa R; Mori K; McHugh KP; Morii E; Kondo T; Kitazawa S
J Cell Biochem; 2008 Oct; 105(3):896-904. PubMed ID: 18759249
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
[TBL] [Abstract][Full Text] [Related]
14. Rac1 and Rac2 in osteoclastogenesis: a cell immortalization model.
Wang Y; Belsham DD; Glogauer M
Calcif Tissue Int; 2009 Sep; 85(3):257-66. PubMed ID: 19649754
[TBL] [Abstract][Full Text] [Related]
15. The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis.
Lazrak M; Deleuze V; Noel D; Haouzi D; Chalhoub E; Dohet C; Robbins I; Mathieu D
J Cell Sci; 2004 Mar; 117(Pt 7):1161-71. PubMed ID: 14970264
[TBL] [Abstract][Full Text] [Related]
16. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
Houston IB; Huang KJ; Jennings SR; DeKoter RP
Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
[TBL] [Abstract][Full Text] [Related]
17. Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function.
Hershey CL; Fisher DE
Bone; 2004 Apr; 34(4):689-96. PubMed ID: 15050900
[TBL] [Abstract][Full Text] [Related]
18. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T
Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909
[TBL] [Abstract][Full Text] [Related]
19. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP.
Courtial N; Smink JJ; Kuvardina ON; Leutz A; Göthert JR; Lausen J
FASEB J; 2012 Feb; 26(2):523-32. PubMed ID: 21990371
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
